The News That Matters about the Nuclear Industry Fukushima Chernobyl Mayak Three Mile Island Atomic Testing Radiation Isotope

America now producing medical radioisotopes without use of a nuclear reactor

U.S. FDA Approves NorthStar Medical Radioisotopes’ RadioGenixTMSystem (Technetium Tc 99m Generator) for Non-uranium Sourced Molybdenum-99 (Mo-99) Production of Imaging Isotope Technetium-99m (Tc-99m)– Enables domestic Mo-99 supply produced without uranium for U.S. healthcare –

– First U.S. source of medical radioisotope Mo-99 in more than 25 years –

BELOIT, Wis.–(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, (NorthStar) a company involved in the production and distribution of radioisotopes used for medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved the RadioGenixTM System, an innovative, high tech radioisotope separation platform indicated for use in producing the widely used medical radioisotope technetium-99 (Tc-99m) from NorthStar’s non-uranium based molybdenum-99 (Mo-99). The RadioGenixTM System is indicated as “a technetium Tc 99m generator used to produce sterile, non-pyrogenic Sodium Pertechnate Tc 99m Injection.”There has been no U.S. production of Mo-99, the parent isotope of Tc-99m, for more than 25 years. The supply of Mo-99 has been subject to frequent and sometimes prolonged interruptions, disrupting and often delaying the diagnosis and treatment of patients in need of medically important diagnostic tests that require the use of this radioisotope. Furthermore, current bulk production of Mo-99 is based on enriched uranium which poses significant environmental concerns.“With the FDA’s approval of the RadioGenix System, NorthStar can begin providing its customers with a reliable and environmentally friendly supply of the Mo-99 radioisotope for the United States,” said George P. Messina, Chairman and CEO of NorthStar Medical Radioisotopes. “As the first, and thus far only company to achieve the objective of being the first U.S. producer of Mo-99 in more than 25 years, we are extremely proud to pioneer domestic production of Mo-99 that is independent of uranium-based product. The approval by the FDA will reduce the U.S. healthcare system’s reliance on fragile foreign supply of Mo-99 and the use of enriched uranium target material.  The RadioGenix System allows for automated, on-site separation and preparation of U.S. Pharmacopeia (USP) Sodium Pertechnetate Tc 99m Injection from Mo-99. The RadioGenix is also a platform technology that has the potential ability to apply its separation capabilities at the point-of-care to other radioisotopes in the future, including therapeutic isotopes such as actinium-225/bismuth-213 (which will require FDA approval). ……….

The RadioGenix System is an innovative, high tech system that is approved for processing non-uranium/non highly enriched uranium molybdenum-99 (Mo-99) for the production of the important medical radioisotope, technetium-99m (Tc-99m). Prior to availability of RadioGenix technology, the U.S. supply chain for Mo-99 has been subject to frequent and sometimes severe interruptions which negatively impact patient healthcare. Approved by the U.S. Food and Drug Administration in February 2018, the RadioGenix System is the first and only on-site, automated isotope separation system of its kind for use with non-uranium/non-highly enriched uranium based Mo-99. ………..

February 10, 2018 Posted by  | General NewsLeave a comment Edit

Netherlands project to produce medical isotopes with no need of a nuclear reactor

Steve Dale No Nuclear Waste Dump Anywhere in South Australia, 10 Feb 18  There is also a promising electron accelerator approach too (started in the Netherlands) . Search for “Lighthouse” and you may have to translate the pages. Here is snippet “Lighthouse: next phase production of medical isotopes without a reactor
January 23, 2018
Chip machine manufacturer ASML has found a partner in the Belgian National Institute for Radio Elements (IRE) for the further development of LightHouse, a technology that makes it possible to make medical isotopes in an easy way without the release of radioactive waste. LightHouse was declared the (Dutch) National Icon last year, but is now being further developed by a Belgian company. With this, the phase of feasibility research seems to have been completed and the development is entering a new phase. First production of medical isotopes is expected in 2020.”


February 10, 2018 - Posted by | health, USA

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: